ReviewBiomarker research2025

Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma.

David Kegyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.